Literature DB >> 26133997

A Case of Mesenchymal Chondrosarcoma Arising from the Femoral Vein with 8 Years of Follow-up.

Jianming Guo1, Yongquan Gu2, Lianrui Guo1, Zhu Tong1, Xin Wu1, Jian Zhang1, Zhonggao Wang1.   

Abstract

Mesenchymal chondrosarcoma (MCS) is an infrequent malignancy of bone and soft tissue that is characterized by a peculiar bimorphic histologic pattern with areas of undifferentiated malignant small cells surrounding well-differentiated cartilaginous islands. Involvement of the large vessels is a rare occurrence. Here, we report a case of MCS arising from the femoral vein that was treated by wide-margin resection combined with autogenous vein revascularization and then followed up for 8 years. The long-term postoperative results showed distant metastasis to the pancreas and both lobes of the lung, without recurrence at the primary site. This case indicates that for MCS arising from the femoral vein, although wide-margin resection combined with autogenous vein revascularization may avoid recurrence at the primary site, this treatment strategy has no obvious benefit for controlling long-term distant metastases.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26133997     DOI: 10.1016/j.avsg.2015.04.086

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  3 in total

1.  A Rare Case Report of Mesenchymal Chondrosarcoma with Pancreatic Metastasis.

Authors:  Jian-Jiun Chen; Cheng-Wei Chou
Journal:  Medicina (Kaunas)       Date:  2022-05-05       Impact factor: 2.948

2.  Mesenchymal chondrosarcoma metastasising to the pancreas.

Authors:  Christoph Paasch; Gianluca De Santo; Katherina Renate Boettge; Martin W Strik
Journal:  BMJ Case Rep       Date:  2018-12-31

3.  Primary extraskeletal mesenchymal chondrosarcoma arising from the iliac vein.

Authors:  Hua Zhang; Shuai Wang; Zhihua Cheng; Han Liu
Journal:  Saudi Med J       Date:  2017-10       Impact factor: 1.484

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.